Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Legardy-Williams, Jennifer K.; Carter, Rosalind J.; Goldstein, Susan T.; Jarrett, Olamide D.; Szefer, Elena; Fombah, Augustin E.; Tinker, Sarah C.; Samai, Mohamed; Mahon, Barbara E.

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola

Published Date:

March 17 2020

Source:

Emerg Infect Dis. 26(3):541-548

Language:

English

[PDF-1.30 MB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Legardy-Williams, Jennifer K. ; Carter, Rosalind J. ; Goldstein, Susan T. ; Jarrett, Olamide D. ; Szefer, Elena ; ... More ▼

Description:

Little information exists regarding Ebola vaccine rVSVΔG-ZEBOV-GP and pregnancy. The Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE) randomized participants without blinding to immediate or deferred (18-24 weeks postenrollment) vaccination. Pregnancy was an exclusion criterion, but 84 women were inadvertently vaccinated in early pregnancy or became pregnant <60 days after vaccination or enrollment. Among immediate vaccinated women, 45% (14/31) reported pregnancy loss, compared with 33% (11/33) of unvaccinated women with contemporaneous pregnancies (relative risk 1.35, 95% CI 0.73-2.52). Pregnancy loss was similar among women with higher risk for vaccine viremia (conception before or <14 days after vaccination) (44% [4/9]) and women with lower risk (conception >15 days after vaccination) (45% [10/22]). No congenital anomalies were detected among 44 live-born infants examined. These data highlight the need for Ebola vaccination decisions to balance the possible risk for an adverse pregnancy outcome with the risk for Ebola exposure.

Subject:

[+]

Pubmed ID:

32017677

Pubmed Central ID:

PMC7045819

Document Type:

Journal Article

Place as Subject:

Sierra Leone

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	19-1018-F1.gif	image/gif
	19-1018-F1.jpg	image/jpeg
	19-1018-F2.gif	image/gif
	19-1018-F2.jpg	image/jpeg
	19-1018.nxml	text/xml

No Related Documents.

You May Also Like:

Evidence to recommendations for pre-exposure vaccination with rVSVΔG-ZEBOV-GP vaccine for at-risk adults in the United States

Personal Author:

Choi, Mary

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)

Published Date:

February 6, 2020

Series:

ACIP meeting Ebola Vaccine

Description:

Ebola-04-Choi-508.pdf

File Type:

[PDF - 1.21 MB]
Background

Personal Author:

Choi, Mary

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)

Published Date:

February 6, 2020

Series:

ACIP meeting Ebola Vaccine

Description:

Ebola-02-Choi-508.pdf

File Type:

[PDF - 1.93 MB]
Grading of Recommendations Assessment, Development and Evaluation (GRADE): rVSVΔG-ZEBOV-GP Ebola vaccine

Personal Author:

Cossaboom, Caitlin M.

Corporate Authors:

National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch.

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2020 February 26-27 : Atlanta, GA)

Published Date:

February 6, 2020

Series:

ACIP meeting Ebola Vaccine

Description:

Ebola-03-Cossaboom-508.pdf

File Type:

[PDF - 1.16 MB]
Considerations for use of Ebola vaccine during an emergency response

Personal Author:

Walldorf, Jenny A.; Cloessner, Emily A.; Hyde, Terri B.; MacNeil, Adam;

Corporate Authors:

CDC Emergency Ebola Vaccine Taskforce

Published Date:

September 07 2017

Source:

Vaccine. 37(48):7190-7200

Description:

Vaccination against Ebola virus disease is a tool that may limit disease transmission and deaths in future outbreaks, integrated within traditional Ebola outbreak prevention and control measures. Although a licensed Ebolavirus vaccine (EV) is not yet...

Public Access
Available on:

November 15, 2020
Sierra Leone trial to introduce a vaccine against Ebola (STRIVE)

Personal Author:

Goldstein, Susan

Corporate Authors:

United States. Advisory Committee on Immunization Practices.. National Center for Immunization and Respiratory Diseases (U.S.). STRIVE..

Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2015 October 21 : Atlanta, GA)

Published Date:

October 21, 2015

Description:

Slides from a presentation at the Advisory Committee on Immunization Practices meeting October 21, 2015, Atlanta, GA.slides-2015-10/ebola-goldstein.pdf

File Type:

[PDF - 1.76 MB]